Skip to contentS
SeaStar Medical Holding Corp
S
ICUCWSeaStar Medical Holding Corp Q2 2026 · 10-Q
Revenue$615.00K$615.00K+82.0% vs Q2 2025 Net Income-$3.73M-$3.73MN/M vs Q2 2025 EPS, diluted—
Gross Profit$561,000+80.4% Operating Income-$3,791,000N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
SeaStar Medical Holding Corp · CIK 1831868 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,994,000N/M Margins · derivedGross margin91.2%−0.8 pt vs Q2 2025
Operating margin-616.4%−96.9 pt vs Q2 2025
Net margin-606.5%−14.2 pt vs Q2 2025
ended Jun 30, 2026 · filed Aug 12, 2026 · 43 d after period end